![Markus J. Cappel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus J. Cappel
Voorzitter bij
OSE IMMUNOTHERAPEUTICS
Profiel
Markus J.
Cappel currently works at OSE Immunotherapeutics SA, as Chairman from 2025.
Dr. Cappel also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Business Development, Alkermes, Inc., as Vice President-Business Development from 1998 to 2001, Cygnus, Inc., as Principal, and ChemoCentryx, Inc., as Treasurer & Chief Business Officer from 2007 to 2022.
Dr. Cappel received his undergraduate degree and doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and Masters Business Admin degree from Harvard Business School.
Actieve functies van Markus J. Cappel
| Bedrijven | Functie | Begin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Voorzitter | 30-09-2025 |
Eerdere bekende functies van Markus J. Cappel
| Bedrijven | Functie | Einde |
|---|---|---|
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 18-10-2011 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01-01-2001 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Opleiding van Markus J. Cappel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
40
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Develops and manufactures glucose-monitoring devices | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
